glp-1 news 2025 november Beyond GLP-1: the next wave of weight-loss medication innovation glp-1 compounding news november 2025

If you have sleep apnea and want Zepbound coverage: Check if your employer has a self-funded plan that overrides CVS Caremark's formulary Consider UnitedHealthcare or other insurers that still cover OSA indication [10] Request a formulary exception with sleep study documentation AETNA ZEPBOUND COVERAGE Frequently Asked Questions The picture changes on October 1, 2026

This is related to rapid weight loss and calorie restriction, not the medication itself

Cognition improved in exenatide treated patients in fluid intelligence (baseline 38.4 (8.2), 12 weeks 52.9 (6.6), p = 0.0005), processing speed (baseline 43.7 (9.4), 12 weeks 58.4 (10.4), p = 0.0058) and episodic memory (baseline 49.4 (5.3), 12 weeks 62.1 (13.2), p = 0.0315)

If you are not prompted after setting up your online WW account, go to the app store on your mobile phone

Dulaglutide (Trulicity), another once-weekly GLP-1 agonist, reports injection site reaction rates of approximately 0.7% in its FDA label